Could a simpler pill replace multiple daily inhalations for lung disease patients?
NCT ID NCT07356375
Summary
This study looks at whether switching adults with pulmonary arterial hypertension (PAH) from an inhaled medication that requires multiple daily uses to a twice-daily oral pill improves their quality of life and makes it easier to stick with treatment. Researchers will follow 32 patients whose doctors decide to make this switch in routine care, comparing them to patients who stay on the inhaled medication. The goal is to understand the patient experience to help guide future treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.